TFC Financial Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
AIM
FWIA
DLA
TFC Financial Management's BMY Position: Q2 2026 in Review
TFC Financial Management reduced its Bristol-Myers Squibb (BMY) stake by 6.2% in Q2 2026, selling an estimated $4.71K and leaving 1,250 shares worth $72K. The position accounts for 0.01% of the portfolio, ranked #255.
TFC Financial Management first reported a position in BMY in Q3 2020 and has held it in 24 quarters since. The position peaked at $272K in Q2 2021. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- TFC Financial Management held 1,250 shares of Bristol-Myers Squibb worth $72K as of Q2 2026.
- TFC Financial Management sold 82 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.71K.
- Bristol-Myers Squibb made up 0.01% of TFC Financial Management's portfolio in Q2 2026, its #255 holding.
- TFC Financial Management first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 24 quarters since.
- TFC Financial Management's Bristol-Myers Squibb position peaked at $272K in Q2 2021.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.